Aptevo Therapeutics Inc Stock price
Is Aptevo Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.
Key metrics
Aptevo Therapeutics Inc Stock Analysis
Analyst Opinions
7 Analysts have issued a Aptevo Therapeutics Inc forecast:
Analyst Opinions
7 Analysts have issued a Aptevo Therapeutics Inc forecast:
Aptevo Therapeutics Inc Events
Upcoming Event
Don't miss a Thing! We will send you all news about Aptevo Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Aptevo Therapeutics Inc Stock News
Company Profile
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics to improve patients lives. Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.
| Head office | United States |
| CEO | Mr. White |
| Employees | 33 |
| Founded | 2016 |
| Website | aptevotherapeutics.com |


